Last updated 9 months ago

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

124 patients around the world
Available in Brazil, Argentina, Mexico
GlaxoSmithKline
2Research sites
124Patients around the world
This study is for people with
Multiple myeloma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
DOM Centro de Reumatología - CABA
Recruiting
Ayacucho 1246, CABA, Buenos Aires
Sanatorio Nuestra Señora del Pilar - Bs As
Recruiting
Av. Gaona 3979, B1702 Ciudadela, Provincia de Buenos Aires, Argentina
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy